Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis

Pediatric Diabetes

Volumn 8, Issue 2, 2007, Pages 53-59

  Levitt Katz, Lorraine E ^a   Jawad, Abbas F ^a   Ganesh, Jaya ^a   Abraham, Máire ^a   Murphy, Kathryn ^a   Lipman, Terri H ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

C peptide; Diabetes: Type 1, type 2; IGFBP 1

Indexed keywords

C PEPTIDE; CARBON DIOXIDE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULIN; KETONE; SOMATOMEDIN BINDING PROTEIN 1;

ACANTHOSIS NIGRICANS; ADOLESCENT; AGE; ANTIBODY DETECTION; ASIAN; BIOCHEMISTRY; BODY MASS; CAUCASIAN; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; URINE LEVEL;

ADOLESCENT; BIOLOGICAL MARKERS; C-PEPTIDE; CARBON DIOXIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KETONES; MALE; OBESITY;

EID: 34247381130     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00236.x     Document Type: Conference Paper

References (48)

1. Dean HE, Mandy RLL, Miffed M. Noninsulin dependent diabetes mellitus in Indian children in Manitoba. Can Med Assoc 1992: 147: 52-57.
2. Pinhas-Hamiel O, Dolan LM, Daniels SR et al. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 1996: 128: 608-615.
3. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000: 105: 671-680.
4. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of type 2 diabetes in American Indian children. Diabetologia 1998: 41: 904-910.
5. Pihoker C, Scott CR, Lensing SY, Cradock MM, Smith J. Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Ped 1998: 37: 97-102.
6. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset non-insulin dependent diabetes mellitus at diagnosis. Pediatrics 1997: 100: 84-91.
7. Arnqvist HJ, Littorin B, Nystrom L et al. Difficulties classifying diabetes at presentation in the youth adult. Diabet Med 1993: 10: 606-613.
8. Alberti KGMM. Problems related to definitions and epidemiology of type 2 (non-insulin dependent) diabetes mellitus: Studies throughout the world. Diabetologia 1993: 36: 978-984.
9. Hother-Nielson O, Faber O, Sorenson N et al. Classification of newly diagnosed diabetic children as insulin-requiring or non-insulin requiring based on clinical and biochemical variables. Diabetes Care 1998: 11: 531-537.
10. Katzeff H, Savage P, Barcla-White B. et al. C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin dependent diabetes mellitus). Diabetologia 1985: 28: 264-268.
11. Klingensmith GJ, Coombs LP, Arslanian S et al. for the Today Study Group. Autoantibody Positivity in Subjects Screened for Participation in a Treatment Trial for T2D in Youth: 289-OR. Diabetes 2006: 55 (Suppl. 1): A67.
12. Arslanian S, Bacha F, Gungor N Youth Type 2 Diabetes: What Are the Implications of Positive Islet-Cell Autoantibodies? ADA 66th Annual Meeting, Washington, D.C., June 2006 (Abstract 57-LB).
13. Reinehr T, Schober E, Wiegand S, Thon A, Holl R, DPV-W iss Study Group. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification. Arch Dis Child 2006: 91: 456-458.
14. Katz L, Norris R, Weinzimer S et al. Characteristics of a large urban pediatric population with type 2 diabetes mellitus. Diabetes 2001: 50 (Suppl.2): A380.
15. Libman IM, La Porte RE, Becker D et al. Was there an epidemic of diabetes in non-White adolescents in Allegheny County, PA? Diabetes Care 1998: 21: 1278-1281.
16. Lipman TH, Chang Y, Murphy KM. The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: Evidence of an epidemic. Diabetes Care 2002: 25: 1969-1975.
17. Lipman TH, Jawad A, Murphy K et al. Incidence of type 1 diabetes in Philadelphia is higher in black than white children from 1995-1999: epidemic or misclassification? Diabetes Care 2006: 29: 2391-2395.
18. Lucia J, Knight J, Dahl-Kundin L, Chin N. 7th Annual Report: America's fattest and fittest cities. Men's Fitness 2005: 21: 63-67.
19. Morales A, Schatz D, Wasserfall C et al. Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 2004: 27: 2010-2014.
20. Kobayashi K, Amemiya S, Higashida K et al. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Metabolism 2000: 49: 186-191.
21. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002: 346: 802-810.
22. Glaser NS. Non-insulin dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997: 44: 307-337.
23. Kaufman FR. Diabetes in children and adolescents. Med Clin North Am 1998: 82: 721-737.
24. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding protein in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991: 73: 964-968.
25. Riihimaa PH, Knip M, Ruokonen A, Tapanainen P. Lack of physiological suppression of circulating IGFBP-1 in puberty in patients with insulin dependent diabetes mellitus. Eur J Endocrinol 2002: 147: 235-241.
26. Halldin MU, Brismar K, Tuvemo T, Gustafsson J. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. Clin Endocrinol 2002: 57: 735-743.
27. Frystyk J, Skaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes. Diabetes Metab Res Rev 1999: 15: 314-322.
28. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988: 665: 266-272.
29. Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyafan-Hughes S, Holly JMP, Yudkin JS. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin Endocrinol 1999: 50: 221-228.
30. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. β-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005: 54: 1735-1743.
31. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: Insulin resistance, β-cell failure, or both? Diabetes Care 28: 638-644.
32. Umpaichitra V, Bastian W, Taha D, Banerji MA, Av Ruskin TW, Castells S. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001: 86: 1605-1609.
33. Libman UM, Pietropaolo M, Trucco M, Dorman JS, La Porte RE, Becker DJ. Islet cell autoimmunity in white and black children and adolescents with IDDM. Diabetes Care 1998: 21: 1824-1827.
34. Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab 2004: 89: 2222-2227.
35. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace J. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics E2001: 107: e102.
36. Vandewalle CL, Falorni A, Svanholm S et al. High diagnostic sensitivity of glutamic acid decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995: 80: 846-851.
37. Chen QY, Rowley MJ, Byrne GC et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first degree relatives. Pediatr Res 1993: 34: 785-790.
38. Bonifacio E, Genovese S, Braghi S et al. Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity. Diabetologia 1995: 38: 816-822.
39. Ng WY, Lee Ys, Todd AL, Lui KF, Loke KY, Thai AC. Tyrosine phosphatase-like rotein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: A study of Chinese patients with diabetes mellitus. Autoimmunity 2002: 35: 119-124.
40. Pietropaolo M, Peakman M, Pietropaolo SL et al. Combined analysis of GAD65 and ICA512 (IAA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 1998: 11: 1-10.
41. Gorus FK, Goubert P, Semakula C et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 1997: 4: 95-99.
42. The SEARCH for Diabetes in Youth Study Group. Preliminary Biochemical Typing of Childhood Diabetes: The SEARCH for Diabetes in Youth Study. American Diabetes Association Annual Meeting 2005 (Abstract 1903-P).
43. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997: 20: 484-486.
44. Winter WE. A typical diabetes in blacks. Clin Diabetes 1991: 9: 51-56.
45. Banerji MA, Chaiken RL, Huey H et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of HLA DR3 and DR4: Flatbush diabetes. Diabetes 1994: 43: 741-745.
46. Katz LEL, Weinzimer SA, Mc Knight H, Murphy KM. Clinical follow-up course Of antibody-negative obese children with acanthosis nigricans presenting with diabetic ketoacidosis (DKA). Pediatr Res 2002: 51: 123A-124A.
47. Rosenbloom AL, Joe JR, Young RS, Winter W. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999: 22: 345-354.
48. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP. Maturity - onset diabetes of youth in black Americans. N Engl J Med 1987: 316: 285-291.